NLRP3 activity is central to this relationship in multiple tumour types, due to its role in coupling inflammasome activation to EMT via IL-1β–dependent signalling that engages NF-κB, TGF-β/Smad, and Wnt/β-catenin pathways. The gene discussed is NLRP3; the disease is neoplasm.